TNFα inhibitors for the treatment of rheumatoid arthritis

被引：0
|
作者：
Sany, J [1 ]
Kaiser, MJ [1 ]
机构：
[1] CHU Montpellier, Hop Lapeyronie, Serv Immunorhumatol, F-34295 Montpellier 5, France
来源：
ANNALES DE MEDECINE INTERNE | 2002年 / 153卷 / 01期
关键词：
immunomodulators; TNF alpha inhibitors; anti-TNF alpha monoclonal antibodies; TNF alpha soluble receptors; rheumatoid arthritis; efficacy; tolerance;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Reasons for using TNFalpha inhibitors in rheumatoid arthritis Available agents modulating TNFalpha Adverse effects to TNFalpha inhibitors - Immunogenicity - Infections - Induction of neoplastic disease Which patients should be treated with TNFalpha inhibitors? Monitoring treatment with TNFalpha inhibitors - Choosing an agent - Initiating treatment Patient follow-up Open questions Conclusions.
引用
收藏
页码：34 / 40
页数：7
相关论文
共 50 条
  • [1] TNF inhibitors: A new age in rheumatoid arthritis treatment
    Anderson, DL
    [J]. AMERICAN JOURNAL OF NURSING, 2004, 104 (02) : 60 - +
  • [2] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [3] TNF-α inhibitors and rheumatoid arthritis
    Shire, MG
    Muller, GW
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (05) : 531 - 544
  • [4] Discontinuation of TNFα inhibitors in rheumatoid arthritis and psoriatic arthritis
    Oskarsdottir, Thorunn
    Gunnarsdottir, Anna Ingibjorg
    Gudbjornsson, Bjorn
    Gunnarsson, Petur Sigurdur
    Love, Thorvardur
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 182 - 183
  • [5] The Genetic Biomarkers to Predicting Response of TNF Inhibitors Treatment in Rheumatoid Arthritis
    Bang, So-Young
    Park, Youngho
    Kim, Kwangwoo
    Joo, Young Bin
    Cho, Soo-Kyung
    Choi, Chan-Bum
    Sung, Yoon-Kyoung
    Kim, Tae-Hwan
    Jun, Jae-Bum
    Yoo, Dae-Hyun
    Lee, Hye-Soon
    Bae, Sang-Cheol
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment
    Joachim R. Kalden
    Hendrik Schulze-Koops
    [J]. Nature Reviews Rheumatology, 2017, 13 : 707 - 718
  • [7] Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment
    Kalden, Joachim R.
    Schulze-Koops, Hendrik
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (12) : 707 - 718
  • [8] THREE TNF-A-INHIBITORS FOR TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Ivakhnenko, O.
    Rebrova, O.
    Avxentyeva, M.
    Khachatryan, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A564 - A564
  • [9] TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
    Rubbert-Roth, Andrea
    Atzeni, Fabiola
    Masala, Ignazio Francesco
    Caporali, Roberto
    Montecucco, Carlomaurizio
    Sarzi-Puttini, Piercarlo
    [J]. AUTOIMMUNITY REVIEWS, 2018, 17 (01) : 24 - 28
  • [10] TNF Inhibitors for Rheumatoid Arthritis A Year in Review
    Simsek, Ismail
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2011, 69 (03): : 220 - 224
12345